On November 9, 2017, the Institutional Review Board approved the study protocol for the effect of MDMA on startle testing in healthy volunteers. This MAPS-sponsored study will be conducted by Principal Investigator Barbara Rothbaum, Ph.D., at Emory University in Atlanta, Georgia. Local recruitment via phone screening began on December 13, 2017. In-person screening will begin January 2018. This study will be followed by another study exploring the combination of MDMA with Prolonged Exposure in PTSD patients.
Learn more…
